Trypsin- and SLIGRL-induced Vascular Relaxation and the Inhibition by Benzamidine Derivatives

Summary

Serine proteinases are involved in several physiological processes and elicit profound cellular effects in a variety of tissues. Besides the thrombin receptor a second receptor, activated by trypsin, the proteinase-activated receptor 2 (PAR-2), was cloned and characterized. Both enzymes generate a new extracellular N-terminus by limited proteolytic cleavage which functions as tethered ligand to activate the receptor. Synthetic peptides corresponding to the sequences of the newly generated N-terminus are able to mimic the effects of the enzymes.

In porcine pulmonary arteries trypsin and the receptor-derived peptide SLIGRL elicited an endothelium-dependent transient relaxation of PGF_2α-precontracted vessels. The EC₅₀ values for trypsin and SLIGRL amounted to 1.1 ± 0.2 nM and 5.4 ± 0.6¼M, respectively. Trypsin and SLIGRL caused a homologous desensitization but thrombin and the thrombin receptor-activating peptide SFLLRN were still able to elicit pronounced relaxant effects. The trypsin- and SLIGRL-induced relaxant responses were markedly diminished after blockade of the nitric oxide synthesis by N^G-nitro-L-arginine methyl ester (200 ¼M) and were absent in endothelium-denuded vessels. Indomethacin and hirudin did not influence the relaxant effects. The effect of trypsin but not that of SLIGRL was blocked by the proteinase inhibitor aprotinin suggesting that only proteolytically active trypsin activates the receptor. Benzamidine derivatives of the 3-amidinophenylalanine type with different affinity for trypsin and thrombin inhibited the vascular effects of trypsin (IC₅₀ 0.007-0.7 ¼M) correlating with its antitrypsin activity.

The data suggest that the vascular effects of trypsin and SLIGRL are mediated through activation of PAR-2 which differs from the thrombin receptor.

• References

• 1 Vu T-KH, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991; 64: 1057-1068
• 2 Coughlin SR, Vu T-KH, Hung DT, Wheaton VI. Expression cloning and characterization of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Semin Thromb Hemost 1992; 18: 161-166
• 3 Nystedt S, Emilsson K, Wahlestedt C, Sundelin J. Molecular cloning of a potential proteinase activated receptor. Proc Natl Acad Sci 1994; 91: 9208-9212
• 4 Nystedt S, Emilsson K, Larsson AK, Strobeck B, Sundelin J. Molecular cloning and functional expression of the gene encoding the human proteinase activated receptor. Eur J Biochem 1995; 232: 84-89
• 5 Bohm SK, Kong Bromme D, Smeekens SP, Anderson DC, Connolly A, Kahn M, Nelken NA, Coughlin SR, Payan DG, Bunnett NW. Molecular cloning expression and potential functions of the human proteinase activated receptor 2. Biochem J 1996; 314: 10009-10016
• 6 Blackhart BD, Cuenco G, Toda T, Scarborough RM, Wolf DL, Ramakrish- nan V. The anion-binding exosite is critical for the high affinity binding of thrombin to the human thrombin receptor. Growth Factors 1994; 11: 17-28
• 7 Al-Am B, Saifeddine M, Hollenberg MD. Detection of functional receptors for the proteinase-activated-receptor-2-activating polypeptide, SLIGRL- NH₂in rat vascular and gastric smooth muscle. Can J Physiol Pharmacol 1995; 73: 1203-1207
• 8 Saifeddine M, Al-Ani B, Cheng CH, Wang L, Hollenberg MD. Rat proteinase-activated receptor-2 (PAR-2): cDNA sequence and activity of receptor-derived peptides in gastric and vascular tissue. Br J Pharmacol 1996; 118: 521-530
• 9 Hollenberg MD, Saifeddine M, Al-Ani B. Proteinase-activated receptor-2 in rat aorta: Structural requirements for agonist activity of receptor-activating peptides. Mol Pharmacol 1996; 49: 229-233
• 10 Hwa JJ, GhibaudI L, Williams P, Chintala M, Zhang R, Chatteijee M, Sybertz E. Evidence for the presence of a proteinase-activated receptor distinct from the thrombin receptor in vascular endothelial cells. Circ Res 1996; 78: 581-588
• 11 Santulli RJ, Derian CK, Darrow AL, Tomko KA, Eckardt AJ, Seiberg M, Scarborough RM, Andrade-Gordon P. Evidence for the presence of a protease-activated receptor distinct from the thrombin receptor in human keratinocytes. Proc Natl Acad Sci 1995; 92: 9151-9155
• 12 Mirza H, Yatsula V, Bahou WF. The proteinase activated receptor-2 (PAR-2) mediates mitogenic responses in human vascular endothelial cells. J Clin Invest 1996; 97: 1705-1714
• 13 Ku DD. Mechanism of thrombin-induced endothelium-dependent coronary vasodilatation in dogs: Role of its proteolytic enzymatic activity. J Cardio- vasc Pharmacol 1986; 08: 29-36
• 14 Rapoport RM, Draznin MB, Murad F. Mechanism of adenosine triphosphate-, thrombin-, and trypsin-induced relaxation of rat thoracic aorta. Circ Res 1984; 55: 468-479
• 15 Glusa E, Paintz M. Relaxant and contractile responses of porcine pulmonary arteries to a thrombin receptor activating peptide (TRAP). Naunyn- Schmiedeberg’s Arch Pharmacol 1994; 349: 431-436
• 16 Walsmann P. Über die Reinigung von Thrombinpräparaten. Pharmazie 1968; 23: 401-402
• 17 Chase T, Shaw E. Comparison of the esterase activities of trypsin, plasmin, and thrombin on guanidinobenzoate esters. Titration of the enzymes. Biochemistry 1969; 08: 2212-2224
• 18 Stürzebecher J, Prasa D, Wikström P, Vieweg H. Structure-activity relationships of inhibitors derived from 3-amidinophenylalanine. J Enzyme Inhibition 1995; 09: 87-99
• 19 Stiirzebecher J, Prasa D, Wikstrom P, Vieweg H, Hauptmann J. Synthesis and structure-activity relationships of potent thrombin inhibitors: piper- azides of 3-amidinophenylalanine. J Med Chem 1997; 40: 3091-3099
• 20 Glusa E, Paintz M, Bretschneider E. Relaxant and contractile responses of porcine pulmonary arteries to thrombin and thrombin-receptor activating peptides. Semin Thromb Hemost 1996; 22: 262-265
• 21 Moscatelli D, Rifkin DB. Membrane and matrix localization of proteinases: a common theme in tumor cell invasion and angiogenesis. Biochim Biophys Acta 1988; 948: 67-85
• 22 Hollenberg MD. Protease-mediated signalling: new paradigms for cell regulation and drug development. Trends Pharmacol Sci 1996; 17: 03-06
• 23 Böhm SK, Khitin LM, Grady EF, Aponte G, Payan DG, Bunnett NW. Mechanism of desensitization and resensitization of proteinase-activated receptor-2. J Biol Chem 1996; 271: 22003-22006